Lixte Biotechnology
Yahoo Finance • 2 months ago
LIXTE joins Russell Microcap Index
* LIXTE Biotechnology Holdings (LIXT [https://seekingalpha.com/symbol/LIXT]) on Friday announced its inclusion in the Russell Microcap Index, effective after the close of the U.S. equity markets on June 26, 2026, as part of the annual Ru... Full story
Yahoo Finance • 2 months ago
LIXTE Joins Russell Microcap Index
BOCA RATON, Fla., June 26, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), today announced its inclusion in the Russell Microcap® Index, effective after the close of the U.S. equity... Full story
Yahoo Finance • 3 months ago
LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)
Company to be Renamed NOMAD Power Solutions • First-to-Market with the Mobile, Utility-Grade 1 MW BESS • Addressing a Multi-Hundred-Billion-Dollar Power Capacity Opportunity BOCA RATON, Fla. & WATERBURY, Vt., June 12, 2026 (GLOBE NEWSWI... Full story
Yahoo Finance • 3 months ago
Top Biotech Gainers: TTRX Turns Heads, LIXT Shifts To AI Energy, CNXU Update, QTRX, TRAX On Watch
(RTTNews) - Monday's top gainers include Turn Therapeutics following its interim analysis findings from an atopic dermatitis study; Conexeu Science on progress in its B.R.E.A.S.T. bioprinting program; LIXTE Biotechnology and its strategic... Full story
Yahoo Finance • 4 months ago
LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update
BOCA RATON, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced... Full story
Yahoo Finance • 8 months ago
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering
New York, NY, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a premier investment banking firm, announces its role as exclusive placement agent in a $4.3 million registered direct offering for Lixte Biotechnology Hol... Full story
Yahoo Finance • 12 months ago
LIXTE Biotechnology makes $2.6M initial purchase of digital currency
* LIXTE Biotechnology (NASDAQ:LIXT [https://seekingalpha.com/symbol/LIXT]) said on Wednesday that it has made an initial purchase of cryptocurrencies [https://seekingalpha.com/pr/20228805-lixte-biotechnology-holdings-makes-2_6-million-in... Full story
Yahoo Finance • 12 months ago
LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions
BOCA RATON, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced it has made an initial purchase of cryp... Full story
Yahoo Finance • 12 months ago
Lixte Biotechnology appoints new CFO and board members
* Lixte Biotechnology (NASDAQ:LIXT [https://seekingalpha.com/symbol/LIXT]) appointed Peter Stazzone as chief financial officer. * Lourdes Felix and Guy Primus joined LIXTE’s board of directors. * Former CFO Robert Weingarten and boar... Full story
Yahoo Finance • last year
24/7 Market News: LIXTE Showcases LB-100 at First Global Conference on Oncogenic Signaling Activation as Cancer Therapy
DENVER, Aug. 27, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, highlights the publication of a new manuscript in Trends in C... Full story
Yahoo Finance • last year
24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets
DENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a... Full story
Yahoo Finance • last year
24/7 Market News: LIXTE Biotechnology Spotlight- Revisiting the “Too Much of a Good Thing” Strategy for LB-100
DENVER, Aug. 19, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits the LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT... Full story
Yahoo Finance • last year
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025
Breakthrough Protein Phosphatase 2A inhibitor LB-100 Targets Ovarian Clear Cell Carcinoma, Advanced Soft Tissue Sarcoma, and MSS Metastatic Colon Cancer 24/7 Market News Issues Corrected Information on Previously issued Press Release with... Full story
Yahoo Finance • last year
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025
DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, spotlights LIXTE Biotechnology Holdings (Nasdaq: LIXT), a cli... Full story
- NVDA
Mentioned:
Yahoo Finance • last year
Wednesday's session: gap up and gap down stocks
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. [gap] GAP UP STOCKS TICKER CHANGE COMMENT BSLK [https://www.chartmill.com/stock/quote/BS... Full story
Yahoo Finance • last year
24/7 Market News: LIXTE Biotechnology Holdings Embraces Cryptocurrency in Corporate Treasury Strategy
DENVER, Aug. 13, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that LIXTE Biotechnology Holdings (Nasdaq: LIXT), a c... Full story
Yahoo Finance • last year
LIXTE Biotechnology Holdings Updates Corporate Treasury Policy to Include Cryptocurrency
PASADENA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that its Board of Directors has approved... Full story
Yahoo Finance • last year
LIXTE Biotechnology Holdings Regains Compliance with Nasdaq’s Continued Listing Requirements
Lixte Biotechnology Holdings, Inc. PASADENA, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced it has... Full story
- IXIC
Mentioned:
Yahoo Finance • last year
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $1.5 Million Registered Direct Offering
New York, NY, July 09, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a premier investment banking firm, is pleased to announce the closing of a $1.5 million registered direct offering for Lixte Biotechnology Holdings, Inc. (N... Full story
Yahoo Finance • last year
Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering
PASADENA, CALIF, July 08, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a registered direct offering with accredited in... Full story